Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). GlobalData uses proprietary data and analytics to provide a comprehensive report on the coronary guidewires devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the coronary guidewires market in China was Terumo followed by Asahi Intecc, Abbott Laboratories, Koninklijke Philips, Boston Scientific, Lepu Medical Technology (Beijing), Medtronic, Cook Medical, Japan Lifeline, B. Braun Melsungen, Opsens and Cardinal Health.
The guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: central core, outer covering and flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on guidewire may be either hydrophilic or hydrophobic. A standard coronary guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: a central core, an outer covering and a flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on the guidewire may be either hydrophilic or hydrophobic. FFR Coronary Guidewires, also known as Fractional Flow Reserve Coronary Guidewires, are a specialized type of guidewire that contain an integrated sensor which measures blood pressure and flow within a specific region of a coronary artery during angiography.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the coronary guidewires devices market within China was expected to be over $40m in 2022.
For the latest complete market share analysis of coronary guidewires device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
